Aridis Pharmaceuticals Inc. Common Stock

ARDS

시가총액 US$1123만

상장 폐지됨

ARDS 종목은 2023년 7월 18일에 상장 폐지됐어요.

소개: Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.